Page last updated: 2024-11-02

4-phenylbutyric acid and Hepatolenticular Degeneration

4-phenylbutyric acid has been researched along with Hepatolenticular Degeneration in 2 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumari, N1
Kumar, A1
Thapa, BR1
Modi, M1
Pal, A1
Prasad, R1
van den Berghe, PV1
Stapelbroek, JM1
Krieger, E1
de Bie, P1
van de Graaf, SF1
de Groot, RE1
van Beurden, E1
Spijker, E1
Houwen, RH1
Berger, R1
Klomp, LW1

Other Studies

2 other studies available for 4-phenylbutyric acid and Hepatolenticular Degeneration

ArticleYear
Characterization of mutation spectrum and identification of novel mutations in ATP7B gene from a cohort of Wilson disease patients: Functional and therapeutic implications.
    Human mutation, 2018, Volume: 39, Issue:12

    Topics: Adolescent; Adult; Case-Control Studies; Cell Line; Cell Survival; Child; Child, Preschool; Cohort S

2018
Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.
    Hepatology (Baltimore, Md.), 2009, Volume: 50, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphatases; Carrier Proteins; Cation Transport

2009